Case reports and pharmacovigilance entries rarely give enough detail to show that one form is clearly safer
Given that it is in early stages of development and the lack of clinical data, 5-amino-1MQ's safety and efficacy remain to be thoroughly investigated through comprehensive clinical trials
They may be, peripherally, marked heart congestion and large areas of subendocardial ischemic (pyknotic) myocytes, lung (hemorrhage), liver congestion and kidney congestion, gastrointestinal lesions, portal and caval hypertension and aortal hypotension
Provides real-world safety data (serious side effects rare) and hypothesis-generating observations for future research
Chronic hyperglycemia damages the small blood vessels supplying peripheral nerves (vasa nervorum), creating ischemic nerve injury that begins in the longest nerves first those reaching the toes and gradually spreads proximally in a stocking-glove distribution